Highly rated in
Highly rated in
Check Dr. Gerald B. Appel's experience treating your condition:
About Dr. Gerald B. Appel

Gerald Appel is a Nephrologist in New York, New York. Appel has been practicing medicine for over 51 years and is highly rated in 18 conditions, according to our data. His top areas of expertise are Glomerulonephritis, Membranoproliferative Glomerulonephritis, Nephrotic Syndrome, Focal Segmental Glomerulosclerosis, and Kidney Transplant. He is licensed to treat patients in New York. Appel is currently accepting new patients.

His clinical research consists of co-authoring 109 peer reviewed articles and participating in 8 clinical trials in the past 15 years.


MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Gerald B. Appel it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Gerald B. Appel accepts the following insurance:

  •  Ambetter

Call to see if your plan is accepted.
161 Fort Washington Ave, New York, NY 10032
Other Locations
155 White Plains Road, Tarrytown, NY 10591
Background & Education
Graduate Institution
Albert Einstein College Of Medicine Of Yeshiva University, 1972
Internal Medicine in NY
Hospital Affiliations
NewYork-Presbyterian/Weill Cornell Medical Center
NewYork-Presbyterian/Columbia University Irving Medical Center
Stamford Hospital
Languages Spoken
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients With Chronic Kidney Disease
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy
Lupus Nephritis Biomarker Study: Baseline Characteristics of Patients
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
The Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)
View 7 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
Learn about our expert tiers
Learn more
Similar Doctors